​

Zhengye Biotechnology Ownership | Who Owns Zhengye Biotechnology?


OverviewRevenueFinancialsChart

Zhengye Biotechnology Ownership Summary


Zhengye Biotechnology is owned by 0.21% institutional investors, 16.16% insiders, and 83.62% retail investors. Jane street group is the largest institutional shareholder, holding 0.06% of ZYBT shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in Zhengye Biotechnology shares.

ZYBT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockZhengye Biotechnology0.21%16.16%83.62%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustrySpecialty & Generic Drug Manufacturers Stocks37.69%14.20%48.11%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Jane street group27.26K0.06%$32.71K
Stonex group17.66K0.04%$25.61K
Ubs group4.20K0.01%$5.04K
Winton group---
Morgan stanley---
Geode capital management---
Caitong asset management7.00-$8.00
Tower research capital llc (trc)---
Jpmorgan chase---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonex group17.66K0.00%$25.61K
Tower research capital llc (trc)---
Jane street group27.26K-$32.71K
Jpmorgan chase---
Ubs group4.20K-$5.04K
Winton group---
Morgan stanley---
Geode capital management---
Caitong asset management7.00-$8.00

Top Buyers

HolderShares% AssetsChange
Jane street group27.26K-27.26K
Stonex group17.66K0.00%17.66K
Caitong asset management7.00-6.00
Jpmorgan chase---134.00
Morgan stanley---248.00

Top Sellers

HolderShares% AssetsChange
Geode capital management---29.07K
Winton group---12.73K
Tower research capital llc (trc)---4.91K
Ubs group4.20K--3.79K
Morgan stanley---248.00

New Positions

HolderShares% AssetsChangeValue
Jane street group27.26K-27.26K$32.71K
Stonex group17.66K0.00%17.66K$25.61K

Sold Out

HolderChange
Jpmorgan chase-134.00
Morgan stanley-248.00
Tower research capital llc (trc)-4.91K
Winton group-12.73K
Geode capital management-29.07K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20268-100,268-17.16%-324.10%2-3-25.00%
Mar 31, 20268-20.00%121,043-47.44%-107.64%2-60.00%433.33%
Dec 31, 202510-230,30245.08%-431.02%5-16.67%3-
Sep 30, 20251025.00%158,743-62.25%-42.34%6-25.00%3-
Jun 30, 20258166.67%420,50831375.15%-11241125.00%8166.67%--

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index29.07K0.06%-
The Winton Fund (US) L.P.2.88K0.01%-4.67K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--

ZYBT Ownership FAQ


Who Owns Zhengye Biotechnology?

Zhengye Biotechnology shareholders are primarily institutional investors at 0.21%, followed by 16.16% insiders and 83.63% retail investors. The average institutional ownership in Zhengye Biotechnology's industry, Specialty & Generic Drug Manufacturers Stocks, is 37.69%, which Zhengye Biotechnology falls below.

Who owns the most shares of Zhengye Biotechnology?

Zhengye Biotechnology’s largest shareholders are Jane street group (27.26K shares, 0.06%), Stonex group (17.66K shares, 0.04%), and Ubs group (4.2K shares, 0.01%). Together, they hold 0.10% of Zhengye Biotechnology’s total shares outstanding.

Does Blackrock own Zhengye Biotechnology?

BlackRock is not among the top 10 institutional shareholders of Zhengye Biotechnology.

Who is Zhengye Biotechnology’s biggest shareholder by percentage of total assets invested?

Stonex group is Zhengye Biotechnology’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 17.66K Zhengye Biotechnology shares, valued at 25.61K$.

Who is the top mutual fund holder of Zhengye Biotechnology shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Zhengye Biotechnology shares, with 0.06% of its total shares outstanding invested in 29.07K Zhengye Biotechnology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools